Samuel Seidu (S I Seidu, Sam Seidu, S Seidu)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 31

Top Topics

Cardiovascular Disease

Atrial Fibrillation

Oral Anticoagulants

Systematic Review

Top Venues

Diabetes, obesity & metabolism

Diabetic medicine : a journal of the British Diabetic Association

European journal of epidemiology

Scandinavian cardiovascular journal : SCJ

This page only lists publications with an associated author ORCID identifier.

Publications

Samuel Seidu, Mohammad Abdool, Abdullah Almaqhawi, Thomas J Wilkinson, Setor K Kunutsor, Kamlesh Khunti, Tom Yates
Physical activity and risk of chronic kidney disease: systematic review and meta-analysis of 12 cohort studies involving 1,281,727 participants. European journal of epidemiology (2023)
Samuel Seidu, Mohammad Abdool, Abdullah Almaqhawi, Thomas J Wilkinson, Setor K Kunutsor, Kamlesh Khunti, Tom Yates
Physical activity and risk of chronic kidney disease: systematic review and meta-analysis of 12 cohort studies involving 1,281,727 participants. European journal of epidemiology 38 (3) (2023)
Setor K Kunutsor, Kamlesh Khunti, Samuel Seidu
Racial, ethnic and regional differences in the effect of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes: a systematic review and meta-analysis of cardiovascular outcome trials. Journal of the Royal Society of Medicine (2023)
Kathryn Backholer, Osagie A Ebekozien, Karen Hofman, J Jaime Miranda, Samuel Seidu
Health equity in endocrinology. Nature reviews. Endocrinology (2023)
Elizabeth Hickman, Mansha Seawoodharry, Clare L Gillies, Kamlesh Khunti F MedSci, Samuel Seidu
Deprescribing in cardiometabolic conditions in older patients: a systematic review. GeroScience (2023)
Samuel Seidu, Mohammad Abdool, Abdullah Almaqhawi, Thomas J Wilkinson, Setor K Kunutsor, Kamlesh Khunti, Tom Yates
Physical activity and risk of chronic kidney disease: systematic review and meta-analysis of 12 cohort studies involving 1,281,727 participants. European journal of epidemiology 38 (3) (2023)
Borenyi S Seidu, Hanad Osman, Samuel Seidu
Lifestyle or pharmacotherapy in cardio-metabolic disease prevention. Therapeutic advances in cardiovascular disease 17 (2023)
Sharmin Shabnam, Sophia Abner, Clare L Gillies, Melanie Jane Davies, Terry Dex, Kamlesh Khunti F MedSci, Kamlesh Khunti, Francesco Zaccardi, Samuel Seidu
Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real-world observational study. Diabetes, obesity & metabolism (2023)
Samuel Seidu, Mohammad Abdool, Abdullah Almaqhawi, Thomas J Wilkinson, Setor K Kunutsor, Kamlesh Khunti, Tom Yates
Physical activity and risk of chronic kidney disease: systematic review and meta-analysis of 12 cohort studies involving 1,281,727 participants. European journal of epidemiology 38 (3) (2023)
Samuel Seidu, Harini Willis, Setor K Kunutsor, Kamlesh Khunti
Intensive versus standard blood pressure control in older persons with or without diabetes: a systematic review and meta-analysis of randomised controlled trials. Journal of the Royal Society of Medicine (2023)
Abdullah Almaqhawi, Patrick J Highton, Mukund Narasimhan, Melanie Jane Davies, Kamlesh Khunti F MedSci, Samuel Seidu
Evaluation of quality of diabetic foot examination on YouTube. Diabetic medicine : a journal of the British Diabetic Association (2022)
Samuel Seidu, Clare Gillies, Francesco Zaccardi, Katharine Reeves, Suzy Gallier, Kamlesh Khunti
Temporal trends in admissions for atrial fibrillation and severe bleeding in England: an 18-year longitudinal analysis. Scandinavian cardiovascular journal : SCJ 57 (1) (2022)
Samuel Seidu, Abdullah Almaqhawi, Mohammad Abdool, Setor Kwadzo Kunutsor, Melanie Jane Davies, Kamlesh Khunti F MedSci
Cardiovascular and renal outcomes of initial combination therapy with glucose-lowering agents versus a stepwise approach in newly diagnosed or treatment-naïve type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 24 (8) (2022)
Samuel Seidu, Clare Gillies, Francesco Zaccardi, Katharine Reeves, Suzy Gallier, Kamlesh Khunti
Temporal trends in admissions for atrial fibrillation and severe bleeding in England: an 18-year longitudinal analysis. Scandinavian cardiovascular journal : SCJ 57 (1) (2022)
Louisa Y Herring, Helen M Dallosso, Sally Schreder, Emily J Smith, Ghazala Waheed, Laura J Gray, Kamlesh Khunti, Thomas Yates, Patrick J Highton, Alex V Rowlands, Ian Hudson, Samuel Seidu, Melanie J Davies
Physical Activity after Cardiac EventS (PACES): a group education programme with subsequent text message support designed to increase physical activity in individuals with diagnosed coronary heart disease: a randomised controlled trial. Open heart 8 (1) (2021)
Samuel Seidu, Setor Kwadzo Kunutsor, Pinar Topsever, Kamlesh Khunti
Benefits and harms of sodium-glucose co-transporter-2 inhibitors (SGLT2-I) and renin-angiotensin-aldosterone system inhibitors (RAAS-I) versus SGLT2-Is alone in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Endocrinology, diabetes & metabolism (2021)
Samuel Seidu, Kamlesh Khunti, Tom Yates, Abdullah Almaqhawi, M J Davies, Jack Sargeant
The importance of physical activity in management of type 2 diabetes and COVID-19. Therapeutic advances in endocrinology and metabolism 12 (2021)
Yogini V Chudasama, Francesco Zaccardi, Briana Coles, Clare L Gillies, Christian Hvid, Samuel Seidu, Melanie Jane Davies, Kamlesh Khunti F MedSci
Ethnic, social and multimorbidity disparities in therapeutic inertia: A UK primary care observational study in patients newly diagnosed with type 2 diabetes. Diabetes, obesity & metabolism 23 (11) (2021)
Angharad Woolley, Yogini V Chudasama, Samuel Seidu, Clare L Gillies, Sally Schreder, Melanie Jane Davies, Kamlesh Khunti F MedSci
Influence of sociodemographic characteristics on the preferred format of health education delivery in individuals with type 2 diabetes mellitus and or cardiovascular disease: a questionnaire study. Diabetic medicine : a journal of the British Diabetic Association 37 (6) (2020)
Sachin Khunti, Nitisha Khunti, Samuel Seidu, Kamlesh Khunti F MedSci
Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19). Diabetes, obesity & metabolism 22 (10) (2020)
Kamlesh Khunti, Melanie J Davies, Samuel Seidu
Cardiovascular outcome trials of glucose-lowering therapies. Expert review of pharmacoeconomics & outcomes research 20 (3) (2020)
Samuel Seidu, Clare Gillies, Francesco Zaccardi, Setor Kwadzo Kunutsor, Jamie Hartmann-Boyce, Thomas Yates, Awadhesh Kumar Singh, Melanie J Davies, Kamlesh Khunti
The impact of obesity on severe disease and mortality in people with SARS-CoV-2: A systematic review and meta-analysis. Endocrinology, diabetes & metabolism (2020)
Samuel Seidu, Setor Kwadzo Kunutsor, Kamlesh Khunti
Serum albumin, cardiometabolic and other adverse outcomes: systematic review and meta-analyses of 48 published observational cohort studies involving 1,492,237 participants. Scandinavian cardiovascular journal : SCJ 54 (5) (2020)
Awadhesh Kumar Singh, Clare L Gillies, Ritu Singh, Akriti Singh, Yogini Chudasama, Briana Coles, Samuel Seidu, Francesco Zaccardi, Melanie Jane Davies, Kamlesh Khunti
Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes, obesity & metabolism 22 (10) (2020)
Kamlesh Khunti F MedSci, Samuel Seidu
Diabetes research in primary care: fiction, reality or essential? Diabetic medicine : a journal of the British Diabetic Association 35 (7) (2019)
Samuel Seidu, Setor K Kunutsor, Howard D Sesso, J M Gaziano, J E Buring, Maria Carla Roncaglioni, Kamlesh Khunti
Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials. Cardiovascular diabetology 18 (1) (2019)
Samuel Seidu, Setor Kwadzo Kunutsor, Kamlesh Khunti
Association of circulating osteocalcin with cardiovascular disease and intermediate cardiovascular phenotypes: systematic review and meta-analysis. Scandinavian cardiovascular journal : SCJ 53 (6) (2019)
Sachin Khunti, Kamlesh Khunti, Samuel Seidu
Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia. Therapeutic advances in endocrinology and metabolism 10 (2019)
Kamlesh Khunti F MedSci, Samuel Seidu, Melanie Jane Davies
Should sodium-glucose co-transporter-2 inhibitors be considered as first-line oral therapy for people with type 2 diabetes? Diabetes, obesity & metabolism 21 (2) (2018)
Chandni Jadawji, Winston Crasto, Clare Gillies, Debasish Kar, Melanie Jane Davies, Kamlesh Khunti, Samuel Seidu
Prevalence and progression of diabetic nephropathy in South Asian, white European and African Caribbean people with type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 21 (3) (2018)
Samuel Seidu, M J Davies, A Farooqi, K Khunti
Integrated primary care: is this the solution to the diabetes epidemic? Diabetic medicine : a journal of the British Diabetic Association 34 (6) (2018)